The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease
- PMID: 1362212
- PMCID: PMC1015334
- DOI: 10.1136/jnnp.55.12.1168
The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease
Abstract
Eight patients with Parkinson's disease performed simple reaction time (SRT), uncued, partially and fully cued four choice (CRT) tasks. They were tested on two occasions; on their normal dose of dopaminergic medication and following withdrawal of such medication for an average of 14.4 hours. Disability as rated on the Webster scale was greater in the drug reduced state. Although RTs were generally slower when tested in the drug reduced state than when on medication, few differences emerged. Withdrawal of dopaminergic medication had no effect on unwarned SRT and unwarned and uncued CRT performance. Both on and off medication, the patients benefited from a warning signal presented before the imperative stimulus. In both medication states, the speeding up of RT was greatest with a warning signal presented 200 ms before S2. When the imperative stimulus was unwarned, the temporal predictability of its occurrence speeded RT more when on medication than when off. Advance movement parameter information was used by patients to pre-programme responses both on and off medication. In both medication states, the fully cued CRT was the same as SRT only with the 3200 ms S1-S2 interval. Medication state had no effect on movement time or the number of errors. It is suggested that slowness in motor readiness and motor programming may not be specific to striatal dopamine deficiency but rather a nonspecific concomitant of brain damage.
Similar articles
-
A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease.J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1169-77. doi: 10.1136/jnnp.56.11.1169. J Neurol Neurosurg Psychiatry. 1993. PMID: 8229028 Free PMC article.
-
Simple and choice reaction time and the use of advance information for motor preparation in Parkinson's disease.Brain. 1992 Apr;115 ( Pt 2):539-64. doi: 10.1093/brain/115.2.539. Brain. 1992. PMID: 1606481
-
Cognitive components of reaction time in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1992 Aug;55(8):658-64. doi: 10.1136/jnnp.55.8.658. J Neurol Neurosurg Psychiatry. 1992. PMID: 1527535 Free PMC article.
-
The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication.Neuropsychologia. 2016 Oct;91:163-172. doi: 10.1016/j.neuropsychologia.2016.07.032. Epub 2016 Jul 27. Neuropsychologia. 2016. PMID: 27475264 Review.
-
L-dopa and frontal cognitive function in Parkinson's disease.Adv Neurol. 1993;60:475-8. Adv Neurol. 1993. PMID: 8420173 Review. No abstract available.
Cited by
-
Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.Brain. 2012 Apr;135(Pt 4):1141-53. doi: 10.1093/brain/aws038. Epub 2012 Mar 6. Brain. 2012. PMID: 22396397 Free PMC article.
-
Auditory sensitivity exhibits sexual dimorphism and seasonal plasticity in music frogs.J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2018 Dec;204(12):1029-1044. doi: 10.1007/s00359-018-1301-1. Epub 2018 Oct 30. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2018. PMID: 30377768
-
Characteristics of the sequence effect in Parkinson's disease.Mov Disord. 2010 Oct 15;25(13):2148-55. doi: 10.1002/mds.23251. Mov Disord. 2010. PMID: 20669182 Free PMC article. Clinical Trial.
-
Medication only improves limb movements while deep brain stimulation improves eye and limb movements during visually-guided reaching in Parkinson's disease.Front Hum Neurosci. 2023 Oct 2;17:1224611. doi: 10.3389/fnhum.2023.1224611. eCollection 2023. Front Hum Neurosci. 2023. PMID: 37850040 Free PMC article.
-
Deep brain stimulation of the subthalamic nucleus, but not dopaminergic medication, improves proactive inhibitory control of movement initiation in Parkinson's disease.Neurotherapeutics. 2013 Jan;10(1):154-67. doi: 10.1007/s13311-012-0166-1. Neurotherapeutics. 2013. PMID: 23184315 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials